Kjetil Tasken

Director, Institute for Cancer Research, Oslo University Hospital; Group Leader, Dept. of Cancer Immunol; Professor, Inst. Clinical Medicine, University of Oslo

[Kjetil Tasken @KjetilTasken]

I look forward to attending the attending this #EUCancerMission Event in Brussels, 29 Sept–1 Oct 2026.
An opportunity to connect with stakeholders across Europe discussing how stronger collaborations can help advance the Cancer Mission’s goals.
Join us at https://t.co/BqeD3Pz47E

[Kjetil Tasken @KjetilTasken]

The meeting about #protontherapy at @DNVA1 in September can be viewed at the Academy’s YouTube channel: https://t.co/eAjTUhl7Ty

[Kjetil Tasken @KjetilTasken]

Today we are writing in @Aftenposten about the new #protontherapy centers soon to open @Oslounivsykehus and @haukeland_no.

Read to find out why the cyclotron at the Radiumhospital is named «Ellen Gleditsch».

@DNVA1 #EirikMalinen #MarianneGuren @UniOslo

https://t.co/nBBLy5VCan

[MATRIX @fkbmatrix]

Stort engasjement på Symposium om offentlig tjenesteinnovasjon på @DNVA1 denne uken. Hva kjennetegner offentlig tjenesteinnovasjon? Hvordan sette i gang endringsprosesser? Takk til @KjetilTasken for en fantastisk dag👏

https://t.co/4vdzHkICBo

[Kjetil Tasken @KjetilTasken]

I Sverige sier utdanningsministeren "Vi vet att den här sektorn [livsvitenskap og helse] de facto står för 10 procent av Sveriges export och är en av våra viktiga basnäringar". Også i Norge er helse erklært en eksportnæring... @Regjeringen @DNVA1 @UniOslo

[Kjetil Tasken @KjetilTasken]

Sverige "ska inte vara landet lagom" sier Utbildningsminister Johan Pehrson og annonserer 600 mill kr til life science og helse. I Norge kuttes det i FoU og til sektoren. Er vi i Norge "landet lagom" som legger oss bak i feltet i Europa mhp FoU-satsning?
https://t.co/9KRXJKorA3?

[Kjetil Tasken @KjetilTasken]

Look forward to working with the new strategy for @DNVA1 for 20025-2028!
#AnnelinEriksen #TerjeLohndal @MaritWestergaa1 @vreas_lise #GunnElisabethBirkelund
https://t.co/MnzpkkpAKo

[Kjetil Tasken @KjetilTasken]

Very happy about this funding by #Kreftforeningen, enabling us to continue our program i-tumor immunity by perturbing regulatory T-cell function with small molecules. Exciting times ahead!

[MATRIX @fkbmatrix]

We congratulate all the 27 cancer researchers that today received funding from the Norwegian Cancer Society
👏 We are excited that two projects connected to MATRIX are funded and congratulate @HellandAslaug, @KjetilTasken and their research teams: https://t.co/IN5XfxZ3G6

[MATRIX @fkbmatrix]

We congratulate all the 27 cancer researchers that today received funding from the Norwegian Cancer Society
👏 We are excited that two projects connected to MATRIX are funded and congratulate @HellandAslaug, @KjetilTasken and their research teams: https://t.co/IN5XfxZ3G6

[Oslounivsykehus @Oslounivsykehus]

#Johnson&Johnson joins #IMPRESS-Norway
@HellandAslaug @KjetilTasken @HRussnes @OusResearch @SveaassAnne @PRIMEROSE_EU @PCM4EU
https://t.co/TJMyUMOiZF

[Kjetil Tasken @KjetilTasken]

Outstanding research environments take years to build and only a few budget decisions to tear down, it can literally be done in days... See what we write about this years budget by @Regjeringen from @DNVA1. By reducing investments in R&D we are doing the opposite of Europe.

[Kjetil Tasken @KjetilTasken]

@Oslounivsykehus @forskningsradet Second that!

[Oslounivsykehus @Oslounivsykehus]

Vi er svært glade for tildelingene fra @forskningsradet i dag, som bla. gir midler til å forsette å jobber med celle-genterapi, samt til forprosjekt for protonterapi.
1,3 milliardar kroner til forskingsinfrastruktur (https://t.co/W6OrAHeVF3)

[Kjetil Tasken @KjetilTasken]

@BerendSnijder Congratulations!

[Kjetil Tasken @KjetilTasken]

Congratulations to the Poster Award winners at the #NorwegianCancerSymposium – 70th Anniversary of ICR @Oslounivsykehus

Selected from 118 posters the 1st and 2nd Prize went to #AnetteKathinkaDahl & #TordHompland. The Participants’ Award to #AnneSofieRise -
#ClaireDunn

[PRIME-ROSE @PRIMEROSE_EU]

Attending #ESMO24?
Interested in how the DRUP-like clinical trials are sharing clinical data across borders? Don't miss our poster presentation🗓️15th September 12-13, where we describe how we share clinical outcome data from the different DRUP-like clinical trials. See you there!

[MATRIX @fkbmatrix]

Thank’s to all the organizers for two fantastic days at the Norwegian Cancer Symposium, marking the 70th aniversary of the ICR! Inspiring talks, good discussions, two vibrant poster sessions with almost 200 posters as well as delicious food👏👏👏

[Pål Kristian Selbo @pkselbo]

What a great start for the Norwegian Cancer Symposium by Prof. Douglas Hanahan @EPFL ! #HallmarksofCancer We are also celebrating the 70th anniversary of our Institute for Cancer Research at The Norwegian Radium Hospital 🥳🎉🇳🇴🇳🇴🇳🇴@Oslounivsykehus!

[Helene Knævelsrud @KnVelsrud]

Celebrating 70 years of the Institute for Cancer Research @OusResearch
with great invited speakers, short talks and posters. Kicked off by an update on the Hallmarks of cancer by Prof. Douglas Hanahan.
@CanCell_UiO @Oslounivsykehus

[MATRIX @fkbmatrix]

The Norwegian Cancer Symposium 2024 is marking the 70th anniversary of Institute for Cancer Research at @Oslounivsykehus.
Keynote speaker #DouglasHanahan kicked-off the scientific program with an excellent talk about Hallmarks of Cancer 2024.